Suchergebnisse - "Armuzzi, Alessandro"

PubPharm (427)

41

Real-Life Efficacy of Tofacitinib in Various Situations in Ulcerative Colitis : A Retrospective Worldwide Multicenter Collaborative Study

enthalten in: Inflammatory bowel diseases | 2023

von Resál, T. | Bacsur, P. | Keresztes, C. | +42

42

Healthcare Professional (HCP) and Patient Usability Evaluation and Preferences of Two Auto-injector Devices for Self-Injection of Biosimilars, SB4 and SB5: A Literature Review

enthalten in: Clinical drug investigation | 2023

von Corominas, H. | Young, D. | Cummings, J. | +4

43

Healthcare Professional (HCP) and Patient Usability Evaluation and Preferences of Two Auto-injector Devices for Self-Injection of Biosimilars, SB4 and SB5: A Literature Review

enthalten in: Clinical drug investigation | 2023

von Corominas, H. | Young, D. | Cummings, J. | +4

44

Healthcare Professional (HCP) and Patient Usability Evaluation and Preferences of Two Auto-injector Devices for Self-Injection of Biosimilars, SB4 and SB5: A Literature Review

enthalten in: Clinical drug investigation | 2023

von Corominas, H. | Young, D. | Cummings, J. | +4

45

Sarcopenia : A new route on the map for risk stratification in inflammatory bowel disease

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2023

von Nardone, O. | Armuzzi, A.

CommentOn: Dig Liver Dis. 2023 Jul;55(7):865-871. - PMID 36925319

46

Author's Reply : ``Use of biologics for the management of Crohn's disease''

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2023

von Bonovas, S. | Macaluso, F. | Piovani, D. | +3

CommentOn: Dig Liver Dis. 2023 Jul;55(7):989. - PMID 37193630

47

Checkpoint Inhibitor-Induced Colitis : From Pathogenesis to Management

enthalten in: International journal of molecular sciences | 2023

von Terrin, M. | Migliorisi, G. | Dal Buono, A. | +6

48

SARS-CoV-2 infection in patients with inflammatory bowel disease : comparison between the first and second pandemic waves

enthalten in: BMC gastroenterology | 2023

von Bezzio, C. | Vernero, M. | Costa, S. | +72

49

SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves

enthalten in: BMC gastroenterology | 2023

von Bezzio, C. | Vernero, M. | Costa, S. | +31

50

SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves

enthalten in: BMC gastroenterology | 2023

von Bezzio, C. | Vernero, M. | Costa, S. | +31